Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Fiona Watt wins prestigious Michael Mason Prize 2016.

Dr Fiona Watt, of the Kennedy Institute of Rheumatology is the winner of the prestigious Michael Mason Prize 2016 awarded by the British Society for Rheumatology, for her contributions to the field.

The award represents the increasing interest in osteoarthritis research in recent years and desire to find new ways to treat the disease: osteoarthritis remains the leading cause of joint pain and disability in the UK, and major reason for joint replacement.
- Dr Fiona Watt

Fiona is a Senior Clinical Research Fellow at NDORMS, as well as an honorary consultant rheumatologist at the Nuffield Orthopaedic Centre. Her research work focuses on human clinical studies and trials relevant to osteoarthritis within the Arthritis Research UK Centre for Osteoarthritis Pathogenesis, where she also leads the Clinical Translation theme.

Her research interest is in the early diagnosis, stratification and treatment of osteoarthritis and she is involved with a number of groups and steering committees which focus on the treatment of this condition.

Speaking of her award, Fiona says: "It is a great honour to be this year's recipient of the Michael Mason prize. The award represents the increasing interest in osteoarthritis research in recent years and desire to find new ways to treat the disease: osteoarthritis remains the leading cause of joint pain and disability in the UK, and major reason for joint replacement. Joint injury is the single greatest risk factor for developing osteoarthritis, which often affects people in mid-life.

"Our work relating to the responses of joint tissues to injury and subsequently in individuals with recent joint injury represents work over many years by myself and colleagues at the Kennedy Institute for Rheumatology. By testing discoveries from the laboratory in clinical studies, we aim to find better of ways of predicting the onset of arthritis, and developing medical treatments which can slow or prevent arthritis, and improve joint pain for people with the condition".

The Michael Mason Prize is awarded by the Heberden Committee for excellence in clinical or scientific research in the field of rheumatology. Dr Michael Mason was a renowned clinical rheumatologist, qualified from Oxford and St Bartholomew's Hospital London. His practice was in the wider aspects of rheumatology and together with Dr W S Tegner he established an associated academic professorial unit in Rheumatology in the University of London at the London Hospital Medical College. Additionally he was instrumental in the development of the Bone and Joint Research at the London Hospital Medical College.

Similar stories

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.